Differential regulation of proteasome-dependent estrogen receptor α and β turnover in cultured human uterine artery endothelial cells

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 5, 2003, Pages 2281-2287

  Tschugguel, Walter ^a   Dietrich, Wolf ^a   Zhegu, Zyhdi ^a   Stonek, Felix ^a   Kolbus, Andrea ^a   Huber, Johannes C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INSULIN; LACTACYSTIN; MESSENGER RNA; METHYL GROUP; METHYL UBIQUITIN; PROTEASOME; PROTEASOME INHIBITOR; PUROMYCIN; TAMOXIFEN; UBIQUITIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL STIMULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; UTERINE ARTERY; WESTERN BLOTTING;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTIBODY SPECIFICITY; ARTERIES; BLOTTING, WESTERN; CELL NUCLEUS; CELL-FREE SYSTEM; CELLS, CULTURED; CYCLOHEXIMIDE; CYSTEINE ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; KINETICS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; PUROMYCIN; RECEPTORS, ESTROGEN; RNA, MESSENGER; TAMOXIFEN; UTERUS;

EUKARYOTA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0037692881     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021165     Document Type: Article

References (31)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH 1987 Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105.1110
2. Stampfer MJ, Colditz GA 1991 Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63
3. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/ Progestin Replacement Study (HERS) research group. JAMA 280:605-613
4. Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M 1985 Cloning of human estrogen receptor cDNA. Proc Natl Acad Sci USA 82:7889-7893
5. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
6. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC 2002 Production and actions of estrogen. N Engl J Med 346:340-352
7. Read LD, Greene GL, Katzenellenbogen BS 1989 Regulation of estrogen receptor ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol 3:295-304
8. Alarid ET, Bakopoulos N, Solodin N 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:1522-1534
9. El Khissiin AE, Leclercq G 1999 Implication of proteasome in estrogen receptor degradation. FEBS Lett 448:160-166
10. Hershko A, Ciechanover A 1998 The ubiquitin system. Annu Rev Biochem 67:425-479
11. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
12. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME 1998 Increased expression of estrogen receptor β mRNA in male blood vessels after vascular injury. Circ Res 83:224-229
13. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME 2002 Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 295:505-508
14. Tschugguel W, Stonek F, Zhegu Z, Dietrich W, Schneeberger C, Stimpfl T, Waldhoer T, Vycudilik W, Huber JC 2001 Estrogen increases endothelial carbon monoxide-derived cGMP by a receptor-mediated system. J Clin Endocrinol Metab 86:3833-3839
15. Wang W, Passaniti A 1999 Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NFκB-dependent mechanism. J Cell Biochem 73:321-331
16. Hershko A, Heller H, Elias S, Ciechanover A 1983 Components of ubiquitin-protein ligase system. J Biol Chem 258:8206-8214
17. Kury F, Schneeberger C, Sliutz G, Kubista E, Salzer H, Medl M, Leodolter S, Swoboda H, Zeilinger R, Spona J 1990 Determination of her-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation. Oncogene 5:1403-1408
18. Choi I, Ko C, Park-Sarge OK, Nie R, Hess RA, Graves C, Katzenellenbogen BS 2001 Human estrogen receptor β-specific monoclonal antibodies: characterization and use in studies of estrogen receptor β protein expression in reproductive tissues. Mol Cell Endocr 181:139-150
19. Dick LR, Cruikshank AA, Destree AT, Grenier L, McCormack TA, Melandri FD, Nunes SL, Palombella VJ, Parent LA, Plamondon L, Stein RL 1997 Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured ceils. J Biol Chem 272:182-188
20. Bennett RG, Hamel FG, Duckworth WC 2000 Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. Endocrinology 141:2508-2517
21. El Khissiin A, Cleeren A, Borras M, Leclercq G 1997 Protein synthesis is not implicated in the ligand-dependent activation of the estrogen receptor in MCF-7 cells. J Steroid Biochem Mol Biol 62:269-276
22. Hershko A, Heller H 1985 Occurrence of a polyubiquitin structure in ubiquitin-protein conjugates. Biochem Biophys Res Commum 128:1079-1086
23. Floyd ZE, Trausch-Azar JS, Reinstein E, Clechanover A, Schwartz AL 2001 The nuclear ubiquitin-proteasome system degrades MyoD. J Biol Chem 276: 22468-22475
24. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR 2000 Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97:5930-5935
25. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW 1999 Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96:1858-1862
26. Figtree GA, Webb CM, Collins P 2000 Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J Pharmacol Exp Ther 295:519-523
27. McDonald CC, Stewart HJ 1991 Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee. BMJ 303: 435-437
28. Russell-Jones DL, Umpleby M 1996 Protein anabolic action of insulin, growth hormone and insulin-like growth factor-1. Eur J Endocrinol 135:631-642
29. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139
30. Mosselman S, Polman J, Dijkema R 1996 ER β: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
31. Matsumoto K, Minamitani T, Sequence definition: Homo sapiens mRNA for β-2-microglobulin, complete cds; submitted (16-DEC-1998) to the DBJ/EMBL/ GenBank databases; accession number AB021288